FDA approves 1st automated, tubeless insulin pump for people with

The Omnipod 5 will be immediately available for people ages 6 to 70.
In a story first reported by The New York Times, a revolutionary cell transplant helped restore one man's natural ability to create and regulate insulin, offering him a potential new lease on life.

Why people with type 1 diabetes should (not) avoid these Top 10 AID Systems

Medtronic Diabetes announces world's first approval for MiniMed

FDA approves Tandem Diabetes' advanced hybrid closed-loop controller - Drug Delivery Business

In Case You Missed It: News Roundup for Omnipod® 5 Automated Insulin Delivery (AID) System

Jake Carr on LinkedIn: FDA approves 1st automated, tubeless insulin pump for people with Type 1…

Report: Insulet prevails over Medtrum in France patent spat

From connected pens to artificial pancreases: how innovative technology is transforming the diabetes treatment landscape - Clarivate

Lindsay F. on LinkedIn: FDA approves 1st automated, tubeless insulin pump for people with Type 1…

Tandem's Latest Breakthroughsㅤ

Switching from an Animas Pump—Know Your Options